Phase I/II Study of Preoperative Cetuximab, Capecitabine, and External Beam Radiotherapy in Patients With Rectal Cancer
Induction Cetuximab, Paclitaxel, and Carboplatin Followed by Chemoradiation With Cetuximab, Paclitaxel, and Carboplatin for Stage III/IV Head and Neck Squamous Cancer: A Phase II ECOG-ACRIN Trial (E2303)
Cetuximab Plus Cisplatin–5-Fluorouracil Versus Cisplatin–5-Fluorouracil Alone in First-Line Metastatic Squamous Cell Carcinoma of the Esophagus: A Randomized Phase II Study of the Arbeitsgemeinschaft Internistische Onkologie
Cetuximab and Irinotecan/5-Fluorouracil/Folinic Acid Is a Safe Combination for the First-Line Treatment of Patients With Epidermal Growth Factor Receptor Expressing Metastatic Colorectal Carcinoma
Phase II Study of the Combination of Cetuximab and Weekly Paclitaxel in the First-Line Treatment of Patients With Recurrent And/Or Metastatic Squamous Cell Carcinoma of Head and Neck
Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) Plus Cetuximab in Patients With Metastatic Colorectal Cancer Who Progressed After Oxaliplatin-Based Chemotherapy